Triple Vectors Expand AAV Transfer Capacity in the Retina
Andrea Maddalena(Telethon Institute Of Genetics And Medicine), Alberto Auricchio(Federico II University Hospital)
Cited by 124
Related Papers
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|857
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
|Molecular Therapy|2009|551
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
|Science Translational Medicine|2012|390
Effective delivery of large genes to the retina by dual AAV vectors
|EMBO Molecular Medicine|2013|258